S
The presence of a mutation in the BRCA genes has no significant effect on the risk of death from breast cancer in women with invasive breast cancer, according to a study conducted in Israel and published in the July 12 issue of the New England Journal of Medicine.
Gad Rennert, MD, PhD, of Carmel Medical Center in Haifa, Israel, and colleagues examined breast cancer outcomes based on the presence of three founder mutations in the BRCA1 or BRCA2 genes in Israeli women diagnosed with invasive breast cancer in 1987–1988.
The researchers found that 10% of the women of Ashkenazi Jewish descent carried a mutation. Medical records were available for 1,545 women, which showed that the risk of death from breast cancer was not significantly different in carriers and noncarriers (adjusted hazard ratio, 0.76 for BRCA1 carriers, 1.31 for BRCA2 carriers).
Rennert G, Bisland-Naggan S, Barnett-Griness O, et al. Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations. N Engl J Med. 2007;357:115-123.
Unraveling preeclampsia: Insights into heterogeneity and intravascular inflammation
April 22nd 2024A recent study delved into the intricate clusters of term preeclampsia, shedding light on its diverse manifestations and the pivotal role of intravascular inflammation, paving the way for improved classification and management strategies.
Read More
Personalized opioid protocol for cesarean deliveries: Reduced prescriptions reported
April 19th 2024A recent suggests that implementing a personalized opioid prescription protocol significantly reduces total morphine milligram equivalents and the number of opioid tablets prescribed at discharge following cesarean delivery.
Read More
Long-term mortality risks for women with adverse pregnancy outcomes
April 19th 2024A recent study revealed that women who experience major adverse pregnancy outcomes face heightened long-term mortality risks, shedding light on the need for comprehensive understanding and preventative measures in women's health.
Read More